Orphan drug markets vary greatly. Different regulatory requirements and cultural norms require orphan drug manufacturers to have in-depth knowledge of how to navigate different marketplaces.
But, the potential is great, so certainly worth the effort.
One way orphan drug manufacturers can make their lives easier is by finding an expert who understands the market’s reimbursement and regulatory policy infrastructure.
This A-Z directory of market access experts aims to be your go-to list when you enter a new market for the first time.
Download a copy of the report for:
- a comprehensive list of market access consultants – save time identifying potential experts that can help you enter new markets
- contact info for each consultancy – find out who you should reach out to for more information
- an overview of each consultancy’s area of expertise – interested in MENA-region? Canada? Find someone who can help, no matter what market you are trying to enter
Interested in orphan drugs and market access? You may also be interested in World Orphan Drug Congress USA, taking place on April 23-25, 2014.
World Orphan Drug Congress USA is the largest international, commercially-focused event for the advancement of rare disease research and orphan drug development. This is your chance to network with and learn from leaders in the global orphan drug community.
Are you a market access consultant? If so you may want to sponsor the event to showcase your expertise to senior decision-makers from the world’s leading orphan drug manufacturers. Download the partnership prospectus for more information on how you can get involved.